Skip to main content
. 2023 Aug 1;13:12470. doi: 10.1038/s41598-023-39669-3

Figure 4.

Figure 4

Validation of the disulfidptosis-related lncRNA signature. (A,B) The disulfidptosis-related lncRNA signature was shown to be an independent risk factor for patients' overall survival in TCGA. (C) The AUC showed that index (risk score) was an independent predictor compared with other clinicopathological signatures. (D) The C-Index of the DLI (risk score) was higher than other clinicopathological signatures. (E) The DLI could be used as an independent predictor to predict the OS of 1-, 3-, 5 years. (F) The nomogram of DLI combined with other clinical features. (G) PCA of all genes. (H) PCA of disulfidptosis-related genes. (I) PCA of disulfidptosis-related lncRNAs. (J) PCA of DLI.